Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Unigene Laboratories reveals bioequivalency results for osteoporosis drug

Feb. 7, 1997

Alza signs licensing agreements for transdermal testesterone products

Feb. 7, 1997

Progress in Bone Care's vitamin D pipeline

Feb. 7, 1997

Nonantiresorptive substituted bisphosphonate disclosed by Gador

Feb. 7, 1997

FDA approval for Ferring antifertility Rx

Feb. 6, 1997

Antiobesity agent from Neurogen/Pfizer advances to multiple-dose trials

Feb. 6, 1997

Impotence Rx expected to enter phase II this year

Feb. 5, 1997

FDA panel to review Carticel service

Feb. 5, 1997

GelMed receives patent coverage for new use of polymers

Feb. 4, 1997

Novel diabetes treatments reported by Shaman

Feb. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...